For: | Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i26/1110.htm |
Number | Citing Articles |
1 |
Dana Balitzer, Sanjay Kakar. Diagnostic challenges and risk stratification of hepatocellular adenoma. Diagnostic Histopathology 2022; 28(2): 89 doi: 10.1016/j.mpdhp.2021.11.003
|
2 |
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Ogawa, Masayuki Kitano, Ijin Joo, Junichi Arita, Ja-Der Liang, Hsi-Ming Lin, Christian Nolsoe, Odd Helge Gilja, Masatoshi Kudo. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 2020; 39(3): 191 doi: 10.14366/usg.20057
|
3 |
Michael Torbenson. Hepatic Adenomas. Surgical Pathology Clinics 2018; 11(2): 351 doi: 10.1016/j.path.2018.02.007
|
4 |
Paulette Bioulac‐Sage, Annette S H Gouw, Charles Balabaud, Christine Sempoux. Hepatocellular adenoma: what we know, what we do not know, and why it matters. Histopathology 2022; 80(6): 878 doi: 10.1111/his.14605
|